Frontpage (v0)
MultiPark
MultiPark (Multidisciplinary Parkinson and Alzheimer Research) is a strategic research area (SRA) supported by the Swedish Government. Through a comprehensive scientific programme we aim at unraveling basic disease mechanisms, improving diagnostics precision, and developing efficient methods of treatment and carefor people affected by neurodegenerative diseases. Building on a tradition of excellence in dopamine research at Lund University, the MultiPark programme was originally focused on Parkinson’s disease. Our network has gradually expanded to incorporate excellent research groups studying Alzheimer´s and Huntington´s disease, or neurodegeneration secondary to brain trauma and stroke.
Calendar
News

Brain activation pattern behind impulsivity in Parkinson’s treatment discovered

Protein mismanagement in brain's control center fuels early symptoms in neurodegenerative diseases

Meet Our Scientists Podcast: Gesine Paul-Visse about the brain’s frontline

More opportunities to test for Alzheimer’s using new analytical method
